| LEUPROLIDE ACETATE | None | ||
| 7.5MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ELIGARD ® is a gonadatropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer. | |||
|
Yes
| |||
| ELIGARD KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||
| ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | *********** **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* ******* *********** | ************* ******* ********* | ************* ******* *********** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********** ****** ** ******** ********* |
| LEUPROLIDE ACETATE | None | ||
| 22.5MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ELIGARD ® is a gonadatropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer. | |||
|
Yes
| |||
| ELIGARD KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||
| ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | *********** **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* ******* *********** | ************* ******* ********* | ************* ******* *********** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******* ******* | ********** ****** ** ******** ********* | ********* ******* ******* | ********* ******* ******* | ********* ******* ******* |
| LEUPROLIDE ACETATE | None | ||
| 30MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ELIGARD ® is a gonadatropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer. | |||
|
Yes
| |||
| ELIGARD KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||
| ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | *********** **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* ******* *********** | ************* ******* ********* | ************* ******* *********** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******* ******* | ********** ****** ** ******** ********* | ********* ******* ******* | ********* ******* ******* | ********* ******* ******* |
| LEUPROLIDE ACETATE | None | ||
| 45MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ELIGARD ® is a gonadatropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer. | |||
|
Yes
| |||
| ELIGARD KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||
| ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ******* *** ******* *** ****** ******* ***** ********** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | *********** **-**** ******* ******** *** ******* ** ********* *** **** | ************* **-**** ******* ******** *** ******* ** ********* *** **** | ************* ******* *********** | ************* ******* ********* | ************* ******* *********** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******** ************ ** ********** **** ******** ******** | ********* ******* ******* | ********** ****** ** ******** ********* | ********* ******* ******* | ********* ******* ******* | ********* ******* ******* | ********* ******* ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|